Clinical and molecular characterization of HER2 amplified-pancreatic cancer

BACKGROUND: Pancreatic cancer is one of the most lethal and molecularly diverse malignancies. Repurposing of therapeutics that target specific molecular mechanisms in different disease types offers potential for rapid improvements in outcome. Although HER2 amplification occurs in pancreatic cancer,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chou, Angela, Waddell, Nicola, Cowley, Mark J, Gill, Anthony J, Chang, David K, Patch, Ann-Marie, Nones, Katia, Wu, Jianmin, Pinese, Mark, Johns, Amber L, Miller, David K, Kassahn, Karin S, Nagrial, Adnan M, Wasan, Harpreet, Goldstein, David, Toon, Christopher W, Chin, Venessa, Chantrill, Lorraine, Humphris, Jeremy, Mead, R Scott, Rooman, Ilse, Samra, Jaswinder S, Pajic, Marina, Musgrove, Elizabeth A, Pearson, John V, Morey, Adrienne L, Grimmond, Sean M, Biankin, Andrew V
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978667/
https://ncbi.nlm.nih.gov/pubmed/24004612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm482
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados